Cardio-Oncology


A portion of the medicines in patients who have been treated for disease may make lasting damage the heart. Because of chemotherapy or radiation, cardiovascular intricacies, for example, premature blockage of arteries of heart, heart rhythm disorders and cardiovascular breakdown may develop. Chemotherapeutic heart lethality is for the most part characterized into 2 kinds: Type 1 chemotherapy-related left ventricular (LV) systolic dysfunction and Type 2 chemotherapy-mediated cardiotoxicity.
Submit Abstract